The severity that the present invention is provided to cure acute lymphoblastic leukemia, reduce the acute lymphoblastic leukemia, or inhibit the method for the growth of the acute lymphoblastic leukemia. The method described in the present invention includes that the bispecific antibody for being specifically binding to CD20 and CD3 of therapeutically effective amount is given to subject in need.
